Naser L. Rezk
- Infectious Diseases top 1%
- Virology top 1%
- Epidemiology top 10%
- Pediatrics, Perinatology and Child Health top 5%
- Molecular Biology
- Co-authors
- Angela D. M. KashubaAmanda CorbettRichard R. TidwellArlene S. BridgesRosa F. YehRustin D. CrutchleyKristine B. PattersonByung Hwa Jung
- Topics
- HIV/AIDS drug development and treatment (27 papers)HIV Research and Treatment (19 papers)HIV/AIDS Research and Interventions (12 papers)
- Partner nations
- United StatesSaudi ArabiaUnited Kingdom
In The Last Decade
Naser L. Rezk
34 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Infectious Diseases 1.1k
- Virology 669
- Epidemiology 347
- Pediatrics, Perinatology and Child Health 208
- Molecular Biology 192
Countries citing papers authored by Naser L. Rezk
This map shows the geographic impact of Naser L. Rezk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naser L. Rezk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naser L. Rezk more than expected).
Fields of papers citing papers by Naser L. Rezk
This network shows the impact of papers produced by Naser L. Rezk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naser L. Rezk. The network helps show where Naser L. Rezk may publish in the future.
Co-authorship network of co-authors of Naser L. Rezk
This figure shows the co-authorship network connecting the top 25 collaborators of Naser L. Rezk. A scholar is included among the top collaborators of Naser L. Rezk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naser L. Rezk. Naser L. Rezk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 40 | |
| 3 | 46 | |
| 4 | Saudi pharmaceutical market: Current, future and R&D | 1 |
| 5 | Innovation in method development; Drugs solubility and stability during bioanalysis process | 0 |
| 6 | 35 | |
| 7 | 16 | |
| 8 | 45 | |
| 9 | 34 | |
| 10 | 127 | |
| 11 | 14 | |
| 12 | 30 | |
| 13 | 146 | |
| 14 | 158 | |
| 15 | 39 | |
| 16 | 159 | |
| 17 | 15 | |
| 18 | 63 | |
| 19 | 67 | |
| 20 | 32 |
About Naser L. Rezk
Naser L. Rezk is a scholar working on Virology, Infectious Diseases and Transplantation, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (12 papers). The work is most often cited by research in Virology (669 citations), Infectious Diseases (1.1k citations) and Pharmacology (130 citations). Naser L. Rezk has collaborated with scholars based in United States, Saudi Arabia and United Kingdom. Frequent co-authors include Angela D. M. Kashuba, Amanda Corbett, Richard R. Tidwell, Arlene S. Bridges, Rosa F. Yeh, Rustin D. Crutchley, Kristine B. Patterson, Byung Hwa Jung, Myron S. Cohen and Nicole White. Their work appears in journals such as Journal of Virology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.